close

Agreements

Date: 2017-10-11

Type of information: Opening of new premises

Compound: Life Science Center in Burlington

Company: Merck KGaA (Germany)

Therapeutic area: Technology - Services

Type agreement: opening of new premises

Action mechanism:

Disease:

Details:

Financial terms:

Latest news:

  • • On October 11, 2017, Merck KGaA officially opened its new Life Science Center in Burlington, Massachusetts. The new center serves as a regional hub for scientific advancement and customer collaboration.The new 280,000-square-foot Life Science Center - now home to nearly 1,000 employees - is designed to leverage the expertise and skills of the best talent in the life science industry. The campus also serves as a premier destination for global customers. In addition to housing both a customer service and call center, the new campus features an M Lab™ Collaboration Center, a shared exploratory environment where the company’s scientists and engineers work with customers to learn about the latest techniques in biomanufacturing.
  • The new Burlington facility was designed and constructed to LEED (Leadership in Energy and Environmental Design) standards — minimizing energy and water consumption, while creating an attractive, convenient and healthy place to work. Some of its innovative features include daylight streaming in from all angles, high-efficiency LED lighting and water fixtures and a 182kW solar photovoltaic system blanketing the roof. Twelve electric vehicle-charging stations, with 24 reserved parking spaces, are available at no cost to employees and visitors. At year-end, Merck KGaA, Darmstadt, Germany, will also open the region’s first BioReliance® End-to-End Biodevelopment Center for small-scale drug manufacturers who will use the lab for their early-phase clinical trials. Customers will get full support, not only with process development or production, but also with regulatory, quality and training.

Is general: Yes